Apollo Medical Files 8-K, Confirms Nasdaq Listing for AMEH

Ticker: ASTH · Form: 8-K · Filed: Jan 10, 2024 · CIK: 1083446

Apollo Medical Holdings, INC. 8-K Filing Summary
FieldDetail
CompanyApollo Medical Holdings, INC. (ASTH)
Form Type8-K
Filed DateJan 10, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: compliance, regulatory-filing, corporate-governance

TL;DR

**Apollo Medical filed a routine 8-K, confirming its Nasdaq listing and SEC compliance.**

AI Summary

Apollo Medical Holdings, Inc. filed an 8-K on January 10, 2024, primarily to disclose its current report status and confirm its registration on The Nasdaq Stock Market LLC under the trading symbol AMEH. This filing, while routine, is important for investors as it reaffirms the company's compliance with SEC regulations and its continued listing on a major exchange, which provides liquidity and visibility for its common stock. It signals that the company is maintaining standard corporate governance and reporting practices.

Why It Matters

This filing confirms Apollo Medical Holdings, Inc.'s ongoing compliance with SEC reporting requirements and its listing on Nasdaq, which is crucial for investor confidence and stock liquidity.

Risk Assessment

Risk Level: low — This 8-K is a standard compliance filing and does not introduce new financial or operational risks.

Analyst Insight

A smart investor would note this as a routine compliance filing, confirming the company's continued good standing on Nasdaq, but it doesn't provide new information for investment decisions.

Key Players & Entities

FAQ

What is the purpose of Apollo Medical Holdings, Inc.'s 8-K filing dated January 10, 2024?

The 8-K filing by Apollo Medical Holdings, Inc. on January 10, 2024, serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily disclosing Regulation FD information and confirming its registration on The Nasdaq Stock Market LLC.

What is the trading symbol for Apollo Medical Holdings, Inc. on The Nasdaq Stock Market LLC?

The trading symbol for Apollo Medical Holdings, Inc.'s Common Stock on The Nasdaq Stock Market LLC is AMEH, as stated in the filing under 'Securities registered pursuant to Section 12(b) of the Act'.

What is the state of incorporation for Apollo Medical Holdings, Inc.?

Apollo Medical Holdings, Inc. is incorporated in Delaware, as indicated in the filing under 'State or Other Jurisdiction of Incorporation'.

What is the business address of Apollo Medical Holdings, Inc.?

The business address of Apollo Medical Holdings, Inc. is 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801, according to the 'Address of Principal Executive Offices' section of the filing.

Does this 8-K filing indicate that Apollo Medical Holdings, Inc. is an emerging growth company?

No, the filing does not indicate that Apollo Medical Holdings, Inc. is an emerging growth company. The checkbox for 'emerging growth company' is not marked in the 'Check the appropriate box below' section.

Filing Stats: 744 words · 3 min read · ~2 pages · Grade level 11.6 · Accepted 2024-01-10 08:00:25

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Attached as Exhibit 99.1 to this Current Report on Form 8-K is a series of slides reflecting financial information about Apollo Medical Holdings, Inc. (the "Company") for use by the Company in connection with potential meetings with investors and/or analysts. The Company does not undertake to update the information contained in the attached presentation materials. The information contained in this Current Report on Form 8-K, including the exhibit referenced herein, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation (January 2024). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. These statements include words such as "forecast," "guidance," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," or "will," or the negative of these words or similar words. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement. A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K/A for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q. The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. APOLLO MEDICAL HOLDINGS, INC. Date: January 10, 2024 By: /s/ Thomas S. Lam Name: Thomas S. Lam, M.D., M.P.H. Title: Co-Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing